PRESS-RELEASE ·Filed Oct 21, 2026
Press release · Earnings
Price Chart
Loading chart...
Executive Summary
Revolution Medicines, Inc. announced it will report its Q3 2026 results on November 4, 2026.
Key Facts
- Revolution Medicines, Inc. announced it will report its Q3 2026 results on November 4, 2026.
Investment Themes
Documents Analyzed
This report is based on 1 press release from GlobeNewswire.
| Document | Accession Number |
|---|---|
| PRESS-RELEASE Data (Synthetic) | press-3385895 |
36 reports for RVMD
70% Hit rate @ T+60 Went positive at some point 15 of 18 best @ T+60▲ +31.56%
Filters
Rows
| Type | Now | ||||
|---|---|---|---|---|---|
Oct 23, 2026 4d ago | Institutional Cluster | $186.99 | awaiting T+60 | awaiting T+60 | $186.22 (−0.41%) |
Oct 21, 2026 6d ago | Press Release | $187.69 | awaiting T+60 | awaiting T+60 | $186.22 (−0.78%) |
Oct 13, 2026 14d ago | 8-K | $193.52 | awaiting T+60 | awaiting T+60 | $186.22 (−3.77%) |
Oct 12, 2026 15d ago | Institutional Cluster | $193.95 | awaiting T+60 | awaiting T+60 | $186.22 (−3.99%) |
Oct 1, 2026 26d ago | Insider Cluster | $206.64 | awaiting T+60 | awaiting T+60 | $186.22 (−9.88%) |
Sep 29, 2026 28d ago | Insider Cluster | $205.26 | awaiting T+60 | awaiting T+60 | $186.22 (−9.28%) |
Sep 28, 2026 29d ago | Insider Cluster | $204.48 | awaiting T+60 | awaiting T+60 | $186.22 (−8.93%) |
Sep 24, 2026 4w ago | Insider Cluster | $204.97 | awaiting T+60 | awaiting T+60 | $186.22 (+9.15%) |
Sep 22, 2026 5w ago | Insider Cluster | $190.74 | awaiting T+60 | awaiting T+60 | $186.22 (+2.37%) |
Sep 18, 2026 5w ago | Insider Cluster | $192.76 | awaiting T+60 | awaiting T+60 | $186.22 (+3.39%) |
Showing 10 of 36
US Market Status
Market Closed · Opens in 5h 5m
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers